IONIS-MAPTRx / Biogen 
Welcome,         Profile    Billing    Logout  
 0 Diseases   1 Trial   1 Trial   3 News 
2 Trials

   

 
Trial + Data / EventsStatusPhNRegionInterventionsSponsorConditionsPrimary complStudy compl
IONIS-MAPTRx / Biogen
CELIA, NCT05399888: A Study to Learn About the Safety of BIIB080 Injections and Whether They Can Improve Symptoms of Participants With Mild Cognitive Impairment Due to Alzheimer's Disease (AD) or Mild AD Dementia Between 50 to 80 Years of Age

Active, not recruiting
2
416
Europe, Canada, Japan, US, RoW
BIIB080, ISIS 814907, BIIB080-matching placebo
Biogen
Mild Cognitive Impairment Due to Alzheimer's Disease, Alzheimer's Disease Dementia
05/26
01/29
NCT06454721: A Study to Determine the Biodistribution, Safety, and Tolerability of a Microdose of Radiolabeled BIIB080 Co-administered With BIIB080 in Healthy Adults

Not yet recruiting
1
5
US
[89Zr]Zr-DFO-BIIB080, BIIB080, ISIS 814907
Biogen
Healthy Volunteer
02/26
07/26

Download Options